Sitemap > Breaking Research > Diagnostics & Devices
Displaying 851 - 900 of 1058 results
- Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation.
- The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
- The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.
- [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
- N(3)-Substituted thymidine analogues V: Synthesis and preliminary PET imaging of N(3)-[(18)F]fluoroethyl thymidine and N(3)-[(18)F]fluoropropyl thymidine.
- Design of (Gd-DO3A)(n)-polydiamidopropanoyl-peptide nucleic acid-d(Cys-Ser-Lys-Cys) magnetic resonance contrast agents.
- Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
- Diagnostic Capacity of 64-Slice Multidetector Computed Tomography for Acute Coronary Syndrome in Patients Presenting with Acute Chest Pain.
- Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.
- Detection and Serotyping of Dengue Virus in Serum Samples by Multiplex Reverse Transcriptase-PCR/LDR Assay.
- The Utility of PAX-2 in Distinguishing Metastatic Clear Cell Renal Cell Carcinoma From its Morphologic Mimics: An Immunohistochemical Study With Comparison to Renal Cell Carcinoma Marker.
- Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
- Interleukin-10 and Interleukin-12 Modulation in Patients with Relapsing-Remitting Multiple Sclerosis on Therapy with Interferon-beta 1a: Differences in Responders and Non Responders.
- Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
- A multiplexed protein microarray for the simultaneous serodiagnosis of human immunodeficiency virus/hepatitis C virus infection and typing of whole blood.
- Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia.
- Mesothelin is a specific biomarker of invasive cancer in the barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.
- A potential thrombus diagnosis reagent based on P-selectin monoclonal antibody SZ-51 light chain.
- Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.
- Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay.
- Tumor cell and tumor vasculature expression of b7-h3 predict survival in clear cell renal cell carcinoma.
- Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.
- A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
- Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer.
- Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
- The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.
- The Chemokine Receptors CXCR4 and CCR7 are Associated with Tumor Size and Pathologic Indicators of Tumor Aggressiveness in Papillary Thyroid Carcinoma.
- Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma.
- HER3 Is a Determinant for Poor Prognosis in Melanoma.
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer.
- Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?
- Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction.
- Clinical role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results.
- Clinical Application of Emerging Sensor Technologies in Diabetes Management: Consensus Guidelines for Continuous Glucose Monitoring (CGM).
- Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.
- Synthesis and bio-evaluation of a new fatty acid derivative for myocardial imaging.
- Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging.
- Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-alpha blockade.
- Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques.
- Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer.
- Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting alpha3 integrin.
- Uptake of inflammatory cell marker [(11)C]PK11195 into mouse atherosclerotic plaques.
- Designed Glycopeptides with Different beta-Turn Types as Synthetic Probes for the Detection of Autoantibodies as Biomarkers of Multiple Sclerosis.
- Evaluation of the Pharmacokinetic Effects of Various Linking Group Using the (111)In-DOTA-X-BBN(7-14)NH2 Structural Paradigm in a Prostate Cancer Model.
- Insulin delivery with FlexPen((R)): dose accuracy, patient preference and adherence.
- Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study.
- BAFF is a Biological Response Marker to IFN-beta Treatment in Multiple Sclerosis.
- Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
- Dosing Accuracy with a Novel Pen Device (SoloSTAR((R))) as Performed by Patients with Diabetes in a Clinical Setting.
- Dose Accuracy Comparison Between SoloSTAR and FlexPen at Three Different Dose Levels.